Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 452

The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.

Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes

Open access
Singh, Siddharth, Dulai, Parambir S., Zarrinpar, Amir, Ramamoorthy, Sonia, Sandborn, William J.·2017·Nature Reviews Gastroenterology & Hepatology

Abstract

Incidence of IBD is rising in parallel with overweight and obesity. Contrary to conventional belief, about 15–40% of patients with IBD are obese, which might contribute to the development of IBD. Findings from cross-sectional and retrospective cohort studies are conflicting on the effect of obesity on natural history and course of IBD. Most studies are limited by small sample size, low event rates, non-validated assessment of disease activity and lack robust longitudinal follow-up and have incomplete adjustment for confounding factors. The effect of obesity on the efficacy of IBD-related therapy remains to be studied, though data from other autoimmune diseases suggests that obesity results in suboptimal response to therapy, potentially by promoting rapid clearance of biologic agents leading to low trough concentrations. These data provide a rationale for using weight loss interventions as adjunctive therapy in patients with IBD who are obese. Obesity also makes colorectal surgery technically challenging and might increase the risk of perioperative complications. In this Review, we highlight the existing literature on the epidemiology of obesity in IBD, discuss its plausible role in disease pathogenesis and effect on disease course and treatment response, and identify high-priority areas of future research.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nrgastro.2016.181

Cites

121 of 121 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 121 references

Research works printed but not linked: 6

  1. Singh, S., Khera, R. & Sandborn, W. J. Obesity is associated with worse outcomes in hospitalized patients with inflammatory bowel diseases: a nationwide study. Am J Gastroenterol. 111, S271 (2016). · doi:10.14309/00000434-201610001-00591
  2. Osterman, M. T. et al. Comparative effectiveness of infliximab and adalimumab for Crohn's disease. Clin. Gastroenterol. Hepatol. 12, 811–817. e3 (2014). · doi:10.1016/j.cgh.2013.06.010
  3. Rosario, M. et al. Population pharmacokinetics-pharmacodynamics of vedolizumab in patients with ulcerative colitis and Crohn's disease. Aliment. Pharmacol. Ther. 42, 188–202 (2015). · doi:10.1111/apt.13243
  4. Bond, A. et al. Comparative analysis of the influence of clinical factors including BMI on adalimumab and infliximab trough levels. Eur. J. Gastroenterol. Hepatol. 28, 271–276 (2016). · doi:10.1097/meg.0000000000000544
  5. Jain, A., Limketkai, B. N. & Hutfless, S. The effect of obesity on post-surgical complications during hospitalizations for inflammatory bowel disease: a nationwide analysis. Gastroenterology 146, S595–S596 (2014). · doi:10.1016/s0016-5085(14)62158-2
  6. Beck, S. J. Stoma issues in the obese patient. Clin. Colon Rectal Surg. 24, 259–262 (2011). · doi:10.1055/s-0031-1295689

Cited by

See all 452

Metadata

Authors
Singh, S., Dulai, P. S., Zarrinpar, A., Ramamoorthy, S., & Sandborn, W. J.
Venue
Nature Reviews Gastroenterology & Hepatology
Published
2016-11-30
Volume
14
Issue
2
Pages
110-121
ISSN
  • 1759-5045 (ISSN-L)
  • 1759-5053
OpenAlex
W2559678284
Cited by
452
References
121
FWCI
2.60
Type
journal article
Language
en
Open access
green
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes. https://app.cochat.ai/papers/10.1038/nrgastro.2016.181
The paper
Singh, S., Dulai, P. S., Zarrinpar, A., Ramamoorthy, S., & Sandborn, W. J. (2017). Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes. Nature Reviews Gastroenterology & Hepatology. https://doi.org/10.1038/nrgastro.2016.181

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.